TP53 and melanoma: While administration of recombinant IL-32γ did not alter the transcriptome of melanoma cells (19) treatment of a human melanoma cell line (HTB-72) with recombinant IL-32α resulted in decreased proliferation of these cells, due to increased expression of the anti-proliferative p21 and p53 in these cells (17).